Magnet.me - Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Het slimme netwerk waar studenten en professionals hun stage of baan vinden.
Je carrière begint op Magnet.me
Maak een profiel aan en ontvang slimme aanbevelingen op basis van je gelikete vacatures.
The Senior Director, CMC Regulatory Affairs is responsible for managing all Chemistry, Manufacturing, and Controls (CMC) regulatory affairs activities for Merus’ product candidates, from the transition from Research to Development through to product licensure.
The role will be responsible for the oversight and leading the development and implementation of CMC regulatory strategies, ensuring timely and compliant regulatory submissions, and managing the coordination of internal and external CMC regulatory activities, including those related to co-development partnerships.
This role requires significant expertise in regulatory affairs for biologics and/or bio-pharmaceuticals, with a deep understanding of global regulatory frameworks (EU/US), GMP, GLP, GCP, GDP, and GRP. The Senior Director will work cross-functionally to ensure seamless integration of CMC regulatory strategies into development programs, enabling the timely progression of clinical trials and product development. This position is based in Utrecht, the Netherlands.
Areas of Full Responsibility:
Areas of Support:
Key Activities:
Skills and Competencies:
This is a critical role in a fast-growing company that offers the opportunity to influence the regulatory strategy for innovative biologics. As a Senior Director in CMC Regulatory Affairs at Merus, you will play a key role in advancing groundbreaking therapies to treat cancer and other serious diseases. You’ll have the chance to make a significant impact on both the development of new treatments and the long-term success of the organization.
The position is based in Utrecht, the Netherlands, offering a dynamic and supportive work environment with the opportunity to collaborate on a global scale.
At Merus, we are clinically advancing leading-edge, targeted treatments to address the unmet needs of patients with various types of cancer. Utilizing our proprietary technology platforms, we are developing innovative multispecific antibody therapeutics, referred to as Multiclonics.
Deze bedrijfspagina is automatisch gegenereerd en bevat daarom nog weinig informatie. Je vindt meer informatie over ‘bedrijfsnaam’ op hun website: ‘’Carrierewebsite’’
Resources:
Change language to: English
Deze pagina is geoptimaliseerd voor mensen uit Nederland. Bekijk de versie geoptimaliseerd voor mensen uit het Verenigd Koninkrijk.